BASILIXIMAB Side Effects

6956229-1 | Caesarean Section, Complications Of Transplanted Kidney, Cytomegalovirus Infection, Gestational Hypertension, Haemodialysis, Haemolytic Anaemia, Kidney Transplant Rejection, Mental Disorder
on Aug 24, 2010 Female patient from JAPAN , 32 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: caesarean section, complications of transplanted kidney, cytomegalovirus infection (What is cytomegalovirus infection?), gestational hypertension, haemodialysis, haemolytic anaemia, kidney transplant rejection, mental disorder. Basiliximab dosage: . During the same period patient was treated with TACROLIMUS (4 Mg, Unk) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (1 Mg, Unk) (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6927712-X | Abdominal Pain, Alanine Aminotransferase Increased, Angiogram, Arterial Catheterisation, Ascites, Aspartate Aminotransferase Increased, Blood Amylase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Systolic Decreased
Patient was taking Basiliximab (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, angiogram, arterial catheterisation, ascites, aspartate aminotransferase increased, blood amylase increased, blood lactate dehydrogenase increased, blood pressure systolic decreased on Aug 10, 2010 from JAPAN Additional patient health information: Male patient , 54 years of age, was diagnosed with renal transplant, blood pressure increased and. Basiliximab dosage: Unk. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.

6914064-4 | Enterococcal Sepsis, Multi-organ Failure
Adverse event was reported on Aug 03, 2010 by a Female patient taking Basiliximab (View Usage) (Dosage: 20 Mg/day) was diagnosed with acute graft versus host disease, liver transplant (What is liver transplant?) and. Location: UNITED STATES , 66 years of age, After Basiliximab was administered, patient had the following side effects: enterococcal sepsis, multi-organ failure. During the same period patient was treated with TACROLIMUS (0.5-5 Mg/day) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ).

6913977-7 | Abdominal Pain, Alanine Aminotransferase Increased, Angiogram, Arterial Catheterisation, Ascites, Aspartate Aminotransferase Increased, Blood Amylase Increased, Blood Lactate Dehydrogenase Increased, Blood Pressure Systolic Decreased
on Jul 25, 2010 Male patient from JAPAN , 54 years of age, was diagnosed with renal transplant, blood pressure increased and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), alanine aminotransferase increased, angiogram, arterial catheterisation, ascites, aspartate aminotransferase increased, blood amylase increased, blood lactate dehydrogenase increased, blood pressure systolic decreased. Basiliximab dosage: Unk. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ). Patient was hospitalized.


6796151-7 | Anaemia, Blood Creatinine Increased, Complications Of Transplanted Kidney, Cytomegalovirus Infection, Focal Segmental Glomerulosclerosis, Hypotension, Kidney Fibrosis, Nephrosclerosis, Renal Disorder
on Jun 14, 2010 Male patient from JAPAN , 23 years of age, weighting 93.04 lb, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). Patient had the following side effects: anaemia, blood creatinine increased, complications of transplanted kidney, cytomegalovirus infection (What is cytomegalovirus infection?), focal segmental glomerulosclerosis, hypotension, kidney fibrosis, nephrosclerosis, renal disorder. Basiliximab dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

6752281-7 | Blood Alkaline Phosphatase Increased, Blood Parathyroid Hormone Increased, Bone Marrow Oedema, Foot Fracture, Pain In Extremity
Patient was taking Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: blood alkaline phosphatase increased, blood parathyroid hormone increased, bone marrow oedema, foot fracture, pain in extremity on May 20, 2010 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with renal transplant and. Basiliximab dosage: Unk. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (500 Mg, Bid) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), SIROLIMUS (View Sirolimus Review and Sirolimus Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), VALGANCICLOVIR HCL (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), HYDRALAZINE HCL (View Hydralazine Hcl Review and Hydralazine Hcl Label ).

6643116-1 | Anisocytosis, Colectomy, Intestinal Perforation, Lung Operation, Lymphadenectomy, Mediastinal Mass, Necrosis, Pericardial Excision, Peritonitis
Adverse event was reported on Mar 08, 2010 by a Male patient taking Basiliximab (View Usage) (Dosage: Cumulative Dose 40 Mg) was diagnosed with renal and pancreas transplant and. Location: GERMANY , 42 years of age, Patient experienced the following unwanted or unexpected effects: anisocytosis, colectomy, intestinal perforation, lung operation, lymphadenectomy, mediastinal mass, necrosis, pericardial excision, peritonitis. During the same period patient was treated with TACROLIMUS (Unk) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (4 Mg, Qd) (View Methylprednisolone Review and Methylprednisolone Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ).

6525963-X | Enterococcal Infection, Graft Complication, Kidney Transplant Rejection, Nephrectomy, Nephrostomy, Pyrexia, Renal Failure Acute, Ureteral Disorder, Urinary Tract Infection Enterococcal
on Dec 22, 2009 Male patient from FRANCE , 68 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). Patient had the following side effects: enterococcal infection, graft complication, kidney transplant rejection, nephrectomy, nephrostomy, pyrexia, renal failure acute, ureteral disorder, urinary tract infection enterococcal. Basiliximab dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ). Patient was hospitalized.

6521608-3 | Cystitis Haemorrhagic, Dysuria, Haematuria, Herpes Simplex, Kidney Transplant Rejection, Pollakiuria
on Dec 17, 2009 Male patient from BRAZIL , 72 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: cystitis haemorrhagic, dysuria, haematuria, herpes simplex (What is herpes simplex?), kidney transplant rejection, pollakiuria. Basiliximab dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6517641-8 | Ascites, Diarrhoea, Douglas' Abscess, Dyspnoea, Fluid Retention, Hypovolaemic Shock, Leukocytosis, Lymphocele, Lymphocele Marsupialisation
Patient was taking Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, diarrhoea, douglas' abscess, dyspnoea, fluid retention, hypovolaemic shock, leukocytosis, lymphocele, lymphocele marsupialisation on Dec 17, 2009 from SPAIN Additional patient health information: Female patient , 66 years of age, was diagnosed with renal transplant and. Basiliximab dosage: Unk. During the same period patient was treated with TACROLIMUS (Unk) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

6508131-7 | Ascites, Diarrhoea, Douglas' Abscess, Dyspnoea, Fluid Retention, Hypovolaemic Shock, Leukocytosis, Lymphocele, Lymphocele Marsupialisation
Adverse event was reported on Dec 17, 2009 by a Female patient taking Basiliximab (View Usage) (Dosage: Unk) was diagnosed with renal transplant and. Location: SPAIN , 66 years of age, Patient had the following side effects: ascites, diarrhoea, douglas' abscess, dyspnoea, fluid retention, hypovolaemic shock, leukocytosis, lymphocele, lymphocele marsupialisation. During the same period patient was treated with TACROLIMUS (Unk) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6507324-2 | Sepsis
on Dec 17, 2009 Female patient from , 53 years of age, was diagnosed with graft versus host disease and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: sepsis (What is sepsis?). Basiliximab dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ).

6461898-9 | Abscess Bacterial, Acute Respiratory Failure, Cytomegalovirus Colitis, Cytomegalovirus Hepatitis, Cytomegalovirus Infection, Enterococcal Bacteraemia, Hepatic Infiltration Eosinophilic, Hepatic Necrosis, Inflammation
on Nov 24, 2009 Male patient from UNITED STATES , 54 years of age, was diagnosed with renal transplant, liver transplant (What is liver transplant?) and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: abscess bacterial, acute respiratory failure, cytomegalovirus colitis, cytomegalovirus hepatitis, cytomegalovirus infection (What is cytomegalovirus infection?), enterococcal bacteraemia, hepatic infiltration eosinophilic, hepatic necrosis, inflammation. Basiliximab dosage: Unk. During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), HEPATITIS B IMMUNE GLOBULIN (HUMAN) (View Hepatitis B Immune Globulin (human) Review and Hepatitis B Immune Globulin (human) Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

6404784-2 | Brain Abscess, Brain Oedema, Cerebral Aspergillosis, Depressed Level Of Consciousness, Enterobacter Infection, Haemophilus Infection, Hepatic Enzyme Increased, Lower Respiratory Tract Infection
Patient was taking Basiliximab (View Usage). Patient had the following side effects: brain abscess, brain oedema, cerebral aspergillosis, depressed level of consciousness, enterobacter infection, haemophilus infection, hepatic enzyme increased, lower respiratory tract infection on Oct 07, 2009 from CANADA Additional patient health information: Female patient , 34 years of age, was diagnosed with transplant and. Basiliximab dosage: . During the same period patient was treated with PREDNISONE (40 Mg/daily) (View Prednisone Review and Prednisone Label ), THYMOGLOBULIN (View Thymoglobulin Review and Thymoglobulin Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ), SULFAMETHOXAZOLE (View Sulfamethoxazole Review and Sulfamethoxazole Label ). Patient was hospitalized.

6369097-6 | Gastrointestinal Haemorrhage, Pneumonia Necrotising, Pseudomonas Infection
Adverse event was reported on Sep 17, 2009 by a Female patient taking Basiliximab (View Usage) (Dosage: Unk) was diagnosed with liver transplant (What is liver transplant?) and. Location: ARGENTINA , 40 years of age, After Basiliximab was administered, patient had the following side effects: gastrointestinal haemorrhage, pneumonia necrotising, pseudomonas infection. During the same period patient was treated with CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ).

6267661-6 | Anuria, Bone Marrow Failure, Candida Sepsis, Diarrhoea, Febrile Neutropenia, Haematochezia, Haematotoxicity, Kidney Transplant Rejection
on Jul 08, 2009 Female patient from TURKEY , 57 years of age, was diagnosed with renal transplant, kidney transplant rejection, antiviral prophylaxis and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: anuria, bone marrow failure, candida sepsis, diarrhoea, febrile neutropenia, haematochezia, haematotoxicity, kidney transplant rejection. Basiliximab dosage: 20 Mg. During the same period patient was treated with MYCOPHENOLIC ACID (Unk) (View Mycophenolic Acid Review and Mycophenolic Acid Label ), METHYLPREDNISOLONE (50 Mg) (View Methylprednisolone Review and Methylprednisolone Label ), MYCOPHENOLATE MOFETIL (1 G/d) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), ANTITHYMOCYTE IMMUNOGLOBULIN (150 Mg/day) (View Antithymocyte Immunoglobulin Review and Antithymocyte Immunoglobulin Label ), VALGANCICLOVIR HCL (450 Mg, Bid) (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), SULFAMETHOXAZOLE AND TRIMETHOPRIM (View Sulfamethoxazole And Trimethoprim Review and Sulfamethoxazole And Trimethoprim Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ). Patient was hospitalized.

6255166-8 | Aortic Aneurysm Rupture, Pseudomonas Infection, Subarachnoid Haemorrhage
on Jun 29, 2009 Female patient from ITALY , 57 years of age, was diagnosed with renal transplant, immunosuppression and was treated with Basiliximab (View Usage). Patient had the following side effects: aortic aneurysm rupture, pseudomonas infection, subarachnoid haemorrhage. Basiliximab dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6255164-4 | Abdominal Pain Lower, Aortic Aneurysm Rupture, Arteritis Infective, Graft Loss, Haemorrhage, Pseudomonas Infection, Pyrexia, Retroperitoneal Effusion
Patient was taking Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: abdominal pain lower, aortic aneurysm rupture, arteritis infective, graft loss, haemorrhage, pseudomonas infection, pyrexia, retroperitoneal effusion on Jun 29, 2009 from ITALY Additional patient health information: Male patient , 57 years of age, was diagnosed with renal transplant, immunosuppression and. Basiliximab dosage: . During the same period patient was treated with METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

6180625-6 | Arthralgia, Hypertrophic Osteoarthropathy, Myalgia, Neutropenia, Pain
Adverse event was reported on Apr 27, 2009 by a Male patient taking Basiliximab (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: UNITED STATES , 22 years of age, Patient experienced the following unwanted or unexpected effects: arthralgia, hypertrophic osteoarthropathy, myalgia, neutropenia, pain (What is pain?).

6060789-5 | Blood Albumin Decreased, Blood Creatinine Increased, Glomerulosclerosis, Hypertension, Oedema Peripheral, Proteinuria, Type 1 Diabetes Mellitus, Urine Protein/creatinine Ratio Increased
on Jan 27, 2009 Male patient from ITALY , 18 years of age, was diagnosed with renal transplant, type 1 diabetes mellitus and was treated with Basiliximab (View Usage). Patient had the following side effects: blood albumin decreased, blood creatinine increased, glomerulosclerosis, hypertension, oedema peripheral, proteinuria, type 1 diabetes mellitus, urine protein/creatinine ratio increased. Basiliximab dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ), INSULIN (View Insulin Review and Insulin Label ). Patient was hospitalized.

6054523-2 | Blood Creatinine Increased, Febrile Neutropenia, Kidney Transplant Rejection, Plasmapheresis
on Jan 20, 2009 Female patient from UNITED STATES , 28 years of age, was diagnosed with immunosuppression and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: blood creatinine increased, febrile neutropenia, kidney transplant rejection, plasmapheresis. Basiliximab dosage: Unk. During the same period patient was treated with MYCOPHENOLIC ACID (Unk) (View Mycophenolic Acid Review and Mycophenolic Acid Label ), MYCOPHENOLATE MOFETIL (Unk) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), VALGANCICLOVIR HCL (Unk) (View Valganciclovir Hcl Review and Valganciclovir Hcl Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), TACROLIMUS (Unk) (View Tacrolimus Review and Tacrolimus Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), BORTEZOMIB (View Bortezomib Review and Bortezomib Label ).

6050510-9 | Cardio-respiratory Arrest, Endotracheal Intubation, Pneumonia Influenzal
Patient was taking Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, endotracheal intubation, pneumonia influenzal on Jan 20, 2009 from UNITED STATES Additional patient health information: Male patient , 66 years of age, was diagnosed with neutropenia and. Basiliximab dosage: 3 Doses. During the same period patient was treated with DAPTOMYCIN (View Daptomycin Review and Daptomycin Label ), DACLIZUMAB (One Dose) (View Daclizumab Review and Daclizumab Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ACYCLOVIR SODIUM (View Acyclovir Sodium Review and Acyclovir Sodium Label ), AZTREONAM (View Aztreonam Review and Aztreonam Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

6043803-2 | Blister Infected, Blood Culture Positive, Cardiac Valve Vegetation, Cerebral Infarction, Complications Of Transplanted Liver, Enterococcal Infection, Herpes Zoster, Multi-organ Failure
Adverse event was reported on Jan 15, 2009 by a Male patient taking Basiliximab (View Usage) (Dosage: 20 Mg On Day 0 And Day 4) was diagnosed with liver transplant (What is liver transplant?), antibiotic prophylaxis, prophylaxis against gastrointestinal ulcer, antifungal prophylaxis and. Location: KOREA, REPUBLIC OF , 62 years of age, Patient had the following side effects: blister infected, blood culture positive, cardiac valve vegetation, cerebral infarction, complications of transplanted liver, enterococcal infection, herpes zoster, multi-organ failure. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE 16MG TAB (1000 Mg) (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), CEFTIZOXIME (View Ceftizoxime Review and Ceftizoxime Label ), LEVOFLOXACIN (View Levofloxacin Review and Levofloxacin Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), NYSTATIN (View Nystatin Review and Nystatin Label ).

5962382-9 | Blood Creatinine Increased, Bronchopulmonary Aspergillosis, Chest Pain, Debridement, Heart Transplant Rejection, Pyrexia, Renal Failure Acute, Rhabdomyolysis, Wound Infection
on Nov 14, 2008 Male patient from UNITED STATES , 46 years of age, was diagnosed with heart transplant (What is heart transplant?) and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: blood creatinine increased, bronchopulmonary aspergillosis, chest pain (What is chest pain?), debridement, heart transplant rejection, pyrexia, renal failure acute, rhabdomyolysis, wound infection. Basiliximab dosage: 20 Mg/day. During the same period patient was treated with TACROLIMUS (7 Mg, Bid) (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (1 G, Bid) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISOLONE (30 Mg/day) (View Prednisolone Review and Prednisolone Label ), HEARTMATE (View Heartmate Review and Heartmate Label ), TRIMETHOPRIM (View Trimethoprim Review and Trimethoprim Label ). Patient was hospitalized.

5935835-7 | Enterobacter Infection, Sepsis
on Oct 28, 2008 Male patient from TAIWAN, PROVINCE OF CHINA , 59 years of age, was diagnosed with heart transplant (What is heart transplant?) and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: enterobacter infection, sepsis (What is sepsis?). Basiliximab dosage: 20 Mg/day. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), EVEROLIMUS (View Everolimus Review and Everolimus Label ).

5924017-0 | Lymphadenopathy, Muscular Weakness, Musculoskeletal Pain, Paresis, Sensory Disturbance, Spinal Cord Compression, Spinal Laminectomy, Surgery
Patient was taking Basiliximab (View Usage). Patient had the following side effects: lymphadenopathy, muscular weakness, musculoskeletal pain, paresis, sensory disturbance, spinal cord compression, spinal laminectomy, surgery (What is surgery?) on Oct 14, 2008 from NETHERLANDS Additional patient health information: Male patient , 44 years of age, was diagnosed with lung transplant (What is lung transplant?) and. Basiliximab dosage: . During the same period patient was treated with PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

5906138-1 | Asthenia, Haemodialysis, Infection, Oedema Peripheral, Renal Failure Acute
Adverse event was reported on Sep 29, 2008 by a Male patient taking Basiliximab (View Usage) (Dosage: ) was diagnosed with heart transplant (What is heart transplant?) and. Location: SPAIN , 70 years of age, After Basiliximab was administered, patient had the following side effects: asthenia, haemodialysis, infection (What is infection?), oedema peripheral, renal failure acute. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), SIROLIMUS (View Sirolimus Review and Sirolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

5906137-X | Cachexia, Mobility Decreased, Pulmonary Embolism
on Sep 29, 2008 Male patient from SPAIN , 61 years of age, was diagnosed with heart transplant (What is heart transplant?) and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: cachexia, mobility decreased, pulmonary embolism (What is pulmonary embolism?). Basiliximab dosage: . During the same period patient was treated with SIROLIMUS (View Sirolimus Review and Sirolimus Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ).

5899557-3 | Bladder Cancer, Bladder Neoplasm Surgery, Diabetes Mellitus, Kidney Transplant Rejection, Nephroureterectomy, Ureteric Cancer
on Sep 17, 2008 Female patient from TAIWAN, PROVINCE OF CHINA , 53 years of age, was diagnosed with renal transplant, kidney transplant rejection and was treated with Basiliximab (View Usage). Patient had the following side effects: bladder cancer (What is bladder cancer?), bladder neoplasm surgery, diabetes mellitus, kidney transplant rejection, nephroureterectomy, ureteric cancer. Basiliximab dosage: Unk. During the same period patient was treated with CYCLOSPORINE (Unk) (View Cyclosporine Review and Cyclosporine Label ), SIROLIMUS (Unk) (View Sirolimus Review and Sirolimus Label ), PREDNISONE (Unk) (View Prednisone Review and Prednisone Label ), METHYLPREDNISOLONE (2 G, Unk) (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

5822151-7 | Abdominal Distension, Epstein-barr Viraemia, Gastroenteritis Adenovirus, Gastrointestinal Haemorrhage, Liver Function Test Abnormal, Lymphopenia, Multi-organ Failure, Pleural Effusion, Pneumonia
Patient was taking Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: abdominal distension, epstein-barr viraemia, gastroenteritis adenovirus, gastrointestinal haemorrhage, liver function test abnormal, lymphopenia, multi-organ failure, pleural effusion, pneumonia (What is pneumonia?) on Jul 18, 2008 from ITALY Additional patient health information: Male patient , child 11 years of age, was diagnosed with liver transplant (What is liver transplant?), intestinal transplant and. Basiliximab dosage: 20 Mg, Once/single. During the same period patient was treated with TACROLIMUS (0.075 Mg/kg, Bid) (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE (2 Mg/kg, Qd) (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

5793009-7 | Feeling Hot, Lymphoproliferative Disorder, Metastases To Lung, Pneumonitis Chemical, T-cell Lymphoma
Adverse event was reported on Jun 20, 2008 by a Male patient taking Basiliximab (View Usage) (Dosage: 20 Mg, Once/single) was diagnosed with renal transplant and. Location: JAPAN , 51 years of age, Patient experienced the following unwanted or unexpected effects: feeling hot, lymphoproliferative disorder, metastases to lung, pneumonitis chemical, t-cell lymphoma. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), MEDROL (View Medrol Review and Medrol Label ). Patient was hospitalized.

5746240-0 | Abdominal Compartment Syndrome, Gastrointestinal Inflammation, Intestine Transplant Rejection, Multi-organ Failure, Retro-peritoneal Space Operation, Septic Shock, Staphylococcal Identification Test Positive
on May 19, 2008 Male patient from BRAZIL , 66 years of age, was diagnosed with small intestine transplant and was treated with Basiliximab (View Usage). Patient had the following side effects: abdominal compartment syndrome, gastrointestinal inflammation, intestine transplant rejection, multi-organ failure, retro-peritoneal space operation, septic shock, staphylococcal identification test positive. Basiliximab dosage: Unk, Unk. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ).

5745106-X | Cytomegalovirus Infection, Cytomegalovirus Test Positive, Diarrhoea, Leukopenia, Pyrexia
on May 13, 2008 Male patient from UNITED STATES , 32 years of age, was diagnosed with heart transplant (What is heart transplant?), antiviral prophylaxis and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), cytomegalovirus test positive, diarrhoea, leukopenia, pyrexia. Basiliximab dosage: 20 Mg, Once/single. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), METHYLPREDNISOLONE (500 Mg/d) (View Methylprednisolone Review and Methylprednisolone Label ), MYCOPHENOLATE MOFETIL (1000 Mg, Bid) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE TAB (2.5 Mg/d) (View Prednisone Tab Review and Prednisone Tab Label ), CYTOMEGALOVIRUS IMMUNE GLOBULIN (150 Mg/kg/day) (View Cytomegalovirus Immune Globulin Review and Cytomegalovirus Immune Globulin Label ).

5678922-3 | Agitation, Mechanical Ventilation, Oxygen Saturation Decreased, Pulmonary Oedema, Respiratory Failure
Patient was taking Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: agitation, mechanical ventilation, oxygen saturation decreased, pulmonary oedema, respiratory failure on Mar 20, 2008 from UNITED STATES Additional patient health information: Female patient , child 4 years of age, weighting 30.86 lb, was diagnosed with renal transplant and. Basiliximab dosage: 10 Mg, Unk. During the same period patient was treated with SOLU MEDROL (View Solu-medrol Review and Solu-medrol Label ), KEFZOL (View Kefzol Review and Kefzol Label ), PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PEPCID (View Pepcid Review and Pepcid Label ). Patient was hospitalized.

5629885-8 | Blood Creatinine Increased, Cells In Urine, Chronic Allograft Nephropathy, Kidney Transplant Rejection, Polyomavirus-associated Nephropathy, Renal Impairment
Adverse event was reported on Feb 13, 2008 by a Male patient taking Basiliximab (View Usage) (Dosage: 20 Mg, Unk) was diagnosed with renal transplant and. Location: , 38 years of age, Patient had the following side effects: blood creatinine increased, cells in urine, chronic allograft nephropathy, kidney transplant rejection, polyomavirus-associated nephropathy, renal impairment. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5626009-8 | Ascites, Cardiac Tamponade, Chronic Allograft Nephropathy, Complications Of Transplanted Kidney, Kidney Transplant Rejection, Pericarditis, Pleural Effusion, Primary Effusion Lymphoma, Renal Impairment
on Feb 06, 2008 Male patient from FRANCE , 63 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: ascites, cardiac tamponade, chronic allograft nephropathy, complications of transplanted kidney, kidney transplant rejection, pericarditis, pleural effusion, primary effusion lymphoma, renal impairment. Basiliximab dosage: . During the same period patient was treated with MYCOPHENOLATE MOFETIL (2 G/d) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE TAB (30 Mg/d) (View Prednisone Tab Review and Prednisone Tab Label ), RAPAMYCIN (8 Mg/d) (View Rapamycin Review and Rapamycin Label ), CYCLOSPORINE (250 Mg/d) (View Cyclosporine Review and Cyclosporine Label ). Patient was hospitalized.

5625984-5 | Chronic Allograft Nephropathy, Kidney Transplant Rejection, Polyomavirus-associated Nephropathy
on Feb 06, 2008 Male patient from , 38 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: chronic allograft nephropathy, kidney transplant rejection, polyomavirus-associated nephropathy. Basiliximab dosage: 20 Mg, Unk. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5598185-7 | Blood Creatinine Increased, Bronchopulmonary Aspergillosis, Chest Pain, Debridement, Heart Transplant Rejection, Pyrexia, Renal Failure Acute, Rhabdomyolysis, Wound Infection
Patient was taking Basiliximab (View Usage). Patient had the following side effects: blood creatinine increased, bronchopulmonary aspergillosis, chest pain (What is chest pain?), debridement, heart transplant rejection, pyrexia, renal failure acute, rhabdomyolysis, wound infection on Jan 10, 2008 from UNITED STATES Additional patient health information: Male patient , 46 years of age, was diagnosed with heart transplant (What is heart transplant?) and. Basiliximab dosage: 20 Mg/day. During the same period patient was treated with HEARTMATE (View Heartmate Review and Heartmate Label ), TRIMETHOPRIM SULFATE (View Trimethoprim Sulfate Review and Trimethoprim Sulfate Label ), TACROLIMUS (7 Mg, Bid) (View Tacrolimus Review and Tacrolimus Label ), PREDNISOLONE (30 Mg/day) (View Prednisolone Review and Prednisolone Label ), MYCOPHENOLATE MOFETIL (1 G, Bid) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

5541526-7 | Abdominal Pain, Clostridium Difficile Colitis, Colectomy, Colitis Ischaemic, Complications Of Transplant Surgery, Complications Of Transplanted Kidney, Cytomegalovirus Colitis, Diarrhoea Haemorrhagic, Gastrointestinal Inflammation
Adverse event was reported on Dec 04, 2007 by a Female patient taking Basiliximab (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: ITALY , 42 years of age, After Basiliximab was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), clostridium difficile colitis, colectomy, colitis ischaemic, complications of transplant surgery, complications of transplanted kidney, cytomegalovirus colitis, diarrhoea haemorrhagic, gastrointestinal inflammation. During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), PREDNISONE (View Prednisone Review and Prednisone Label ). Patient was hospitalized.

5467781-X | Abdominal Infection, Aspergillosis, Atelectasis, Blood Bicarbonate Decreased, Blood Creatinine Increased, Bronchial Disorder, Bronchopulmonary Aspergillosis, C-reactive Protein Increased, Cardiac Failure
on Sep 20, 2007 Male patient from BELGIUM , 52 years of age, was diagnosed with renal and pancreas transplant and was treated with Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal infection, aspergillosis, atelectasis, blood bicarbonate decreased, blood creatinine increased, bronchial disorder, bronchopulmonary aspergillosis, c-reactive protein increased, cardiac failure. Basiliximab dosage: 30 Mg, Once/single. During the same period patient was treated with METHYLPREDNISOLONE (6 Mg/d) (View Methylprednisolone Review and Methylprednisolone Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (1 G, Bid) (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ). Patient was hospitalized.

5397409-9 | Blood Creatinine Increased, Diabetes Mellitus, Hepatic Enzyme Increased, Kidney Transplant Rejection, Nephropathy Toxic, Renal Impairment, Renal Vessel Disorder
on Jul 20, 2007 Male patient from EGYPT , 36 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). Patient had the following side effects: blood creatinine increased, diabetes mellitus, hepatic enzyme increased, kidney transplant rejection, nephropathy toxic, renal impairment, renal vessel disorder. Basiliximab dosage: Unk, Unk. During the same period patient was treated with AZATHIOPRINE (2 Mg/kg/d) (View Azathioprine Review and Azathioprine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), CYCLOSPORINE (8 Mg/kg/d) (View Cyclosporine Review and Cyclosporine Label ).

5391144-9 | Blood Creatinine Increased, Kidney Transplant Rejection, Lung Infection, Nocardiosis, Renal Impairment, Renal Tubular Disorder
Patient was taking Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: blood creatinine increased, kidney transplant rejection, lung infection, nocardiosis, renal impairment, renal tubular disorder on Jul 12, 2007 from JAPAN Additional patient health information: Male patient , 59 years of age, was diagnosed with renal transplant and. Basiliximab dosage: Unk, Unk. During the same period patient was treated with CYCLOSPORINE (Unk, Unk) (View Cyclosporine Review and Cyclosporine Label ), SULFAMETHOXAZOLE W/TRIMETHOPRIM (View Sulfamethoxazole W/trimethoprim Review and Sulfamethoxazole W/trimethoprim Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ).

5385032-1 | Kidney Transplant Rejection, Lung Infection, Nocardiosis, Renal Tubular Disorder
Adverse event was reported on Jul 04, 2007 by a Male patient taking Basiliximab (View Usage) (Dosage: ) was diagnosed with renal transplant and. Location: JAPAN , 59 years of age, Patient experienced the following unwanted or unexpected effects: kidney transplant rejection, lung infection, nocardiosis, renal tubular disorder. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

5375873-9 | Adenovirus Infection, Blood Creatinine Increased, Haematuria, Prostate Tenderness, Prostatitis, Pyrexia, Tubulointerstitial Nephritis, Virus Urine Test Positive
on Jun 19, 2007 Male patient from JAPAN , 31 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). Patient had the following side effects: adenovirus infection, blood creatinine increased, haematuria, prostate tenderness, prostatitis, pyrexia, tubulointerstitial nephritis, virus urine test positive. Basiliximab dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ). Patient was hospitalized.

5274815-4 | Anaemia, Cytomegalovirus Antigen Positive, Duodenal Ulcer Haemorrhage, Faeces Discoloured, Gastrectomy, Pylorectomy
on Mar 12, 2007 Male patient from JAPAN , 55 years of age, was diagnosed with renal transplant and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: anaemia, cytomegalovirus antigen positive, duodenal ulcer haemorrhage, faeces discoloured, gastrectomy, pylorectomy. Basiliximab dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

5274091-2 | Anaemia, Cytomegalovirus Antigen Positive, Duodenal Ulcer Haemorrhage, Faeces Discoloured, Gastrectomy, Pylorectomy
Patient was taking Basiliximab (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, cytomegalovirus antigen positive, duodenal ulcer haemorrhage, faeces discoloured, gastrectomy, pylorectomy on Mar 12, 2007 from JAPAN Additional patient health information: Male patient , 55 years of age, was diagnosed with renal transplant and. Basiliximab dosage: . During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), MYCOPHENOLATE MOFETIL (View Mycophenolate Mofetil Review and Mycophenolate Mofetil Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ), RITUXIMAB (View Rituximab Review and Rituximab Label ). Patient was hospitalized.

4745251-1 | Biopsy Liver Abnormal, Blood Bilirubin Increased, Hepatic Congestion, Hepatic Enzyme Increased, Hepatic Haemorrhage, Hepatic Necrosis, Hepatotoxicity, Liver Transplant Rejection
Adverse event was reported on Aug 03, 2005 by a Female patient taking Basiliximab (View Usage) (Dosage: ) was diagnosed with liver transplant (What is liver transplant?) and. Location: JAPAN , 54 years of age, Patient had the following side effects: biopsy liver abnormal, blood bilirubin increased, hepatic congestion, hepatic enzyme increased, hepatic haemorrhage, hepatic necrosis, hepatotoxicity, liver transplant rejection. During the same period patient was treated with CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), METHYLPREDNISOLONE 16MG TAB (View Methylprednisolone 16mg Tab Review and Methylprednisolone 16mg Tab Label ).

4642652-7 | Cytomegalovirus Infection, Graft Haemorrhage, Peritoneal Fluid Analysis Abnormal, Post Procedural Complication, Pyrexia, Staphylococcal Infection
on Apr 06, 2005 Male patient from , 32 years of age, was diagnosed with renal and pancreas transplant and was treated with Basiliximab (View Usage). After Basiliximab was administered, patient had the following side effects: cytomegalovirus infection (What is cytomegalovirus infection?), graft haemorrhage, peritoneal fluid analysis abnormal, post procedural complication, pyrexia, staphylococcal infection (What is staphylococcal infection?). Basiliximab dosage: . During the same period patient was treated with TACROLIMUS (View Tacrolimus Review and Tacrolimus Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), STEROIDS NOS (View Steroids Nos Review and Steroids Nos Label ). Patient was hospitalized.